|Page 64 after line 6, insert:|
"N.1. Out of the amounts provided in this item, $1,500,000 in the first year and $1,500,000 in the second year from the general fund is appropriated to establish a Virginia Biotechnology Wet-Laboratory Program at the Virginia Economic Development Partnership to provide loans, loan guarantees, or grants to construct, improve, furnish, equip, maintain, acquire and renovate biotechnology laboratories designed to accommodate and provide wet-lab space or other needed laboratory, research, or production space to attract biosciences and other related technology companies to the state, as well as to accommodate the growth of companies already located in Virginia. Funds under this program may be used for loan guarantees, credit enhancement, or grants, in cooperation with, or on behalf of, applying local governments, private development entities, or other qualified applicants under the program guidelines.
2. The promulgation of program guidelines, and any decisions regarding the size and scope of the biotechnology “shell buildings,” the selection of sites, and the selection of users, tenants or purchasers of such buildings shall be made by a panel consisting of the Secretary of Commerce and Trade, the President of the Center for Innovative Technology, the Executive Director of the Virginia Economic Development Partnership, the Executive Director of the Virginia Biotechnology Association and the President of a research university selected by the Council of University and College Presidents. The funds shall be administered within the “Virginia Shell Building Initiative” as established pursuant to § 15.2-941, Code of Virginia. By November 15 or each year the Secretary shall provide a detailed report on the number of companies and jobs created pursuant to this funding.
O.1. George Mason University, in collaboration with the University of Virginia, Virginia Tech, Virginia Commonwealth University and Eastern Virginia Medical School shall create a research consortium hereby known as the Virginia Immunology Center. The Virginia Immunology Center is authorized to solicit proposals under the Public-Private Education Facilities and Infrastructure Act (PPEA) to partner with private, for-profit companies to conduct research on vaccines for the treatment of multiple infectious diseases. In no case shall the terms of the public-private partnership obligate the Commonwealth to the appropriation of additional general funds.
2. $1,500,000 in general funds the first year is provided for George Mason University to upgrade laboratory facilities located on its Prince William County campus and to purchase the necessary antibody samples for immunology research. However, no funds authorized in this item shall be allotted or expended until the Virginia Immunology Center and consortium receives an acceptable PPEA proposal and submits the proposal to the Chairmen of the House Appropriations Committee and the Senate Finance Committee for its approval.
3. Antibody samples and/or libraries purchased with these funds are to be made available to all public colleges and universities in the Commonwealth for research purposes and are to be available without any additional charge."